glp-1 mcas Not all GLP-1s work the same way for MCAS. Most patients do better on Tirzepatide, the dual incretin with both and GIP receptor agonists. But some mast cells just respond better Not all GLP-1s work the
Description
Weve been waiting on a GLP-1 study
While effective, these treatments require monitoring due to potential side effects, especially in non-diabetic patients.This therapeutic advancement represents a revolution in the management of metabolic diseases and obesity.Despite their efficacy in managing obesity and metabolic disorders, GLP-1 and GIP receptor agonists can cause side effects, which are a common reason for therapy discontinuation

Key changes every healthcare professional should know: Obesity is formally treated as a chronic, relapsing disease Lifestyle intervention remains essential, but anti-obesity medications are now considered a core component of care, not a last resort
WEDNESDAY, June 17, 2026 (HealthDay News) People with an autoimmune disease and obesity might lower their risk of dangerous blood clots and death by taking Oz

People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, according to a new study.
This is hard to accomplish with a juice concentrate, so I'm guessing these smoothies include at least 1 form of whole fresh fruit
